HIV Medicine, 24(5), 628-639, 2023

Vitamin D intakes among women living with and without HIV in Canada

Shayda A Swann , Jerilynn C Prior , Claudie Berger

Author affiliations (6)
  • University of British Columbia ROR
  • Vancouver Hospital and Health Sciences Centre ROR
  • McGill University ROR
  • Women's Health Research Institute ROR
  • B.C. Women's Hospital & Health Centre ROR
  • Simon Fraser University ROR
DOI10.1111/hiv.13454 PMID36597960
Read at publisher

Abstract

Background

Patterns of vitamin D intake are relatively unexplored among women living with HIV, despite its importance for women's health. We compared vitamin D dietary and supplement intakes in women with HIV and population-based national controls and investigated barriers to intake.

Methods

In this case-control study, women with HIV in the Children and Women: AntiRetrovirals and Markers of Aging (CARMA) cohort were matched with Canadian Multicentre Osteoporosis Study (CaMos) controls. Participants were queried for vitamin D in dairy consumption, supplementation/dosage, and sociodemographic variables. We assessed barriers to supplementation and factors associated with dietary intake by regression modelling.

Results

Ninety-five women living with HIV were age-matched to 284 controls. Women with HIV had lower income and bone mineral density and were more likely to smoke, take multiple medications and be non-white. Vitamin D dietary intake was lower in women living with HIV versus controls [0.76 vs. 1.79 μg/day; adjusted odds ratio (aOR) for greater than or equal to median intake 0.29 (0.12-0.61), p = 0.002], but any supplementation was higher [62.2% vs. 44.7%; aOR = 3.44 (95% CI: 1.16-11.00), p = 0.03]. Total vitamin D intake was similar between groups. Smoking was associated with no supplementation; non-white ethnicity and low income were related to lower dietary intake.

Conclusions

Women living with HIV showed lower dietary vitamin D intake but higher supplementation rates, suggesting that care providers are promoting supplementation. Women living with HIV who smoke, have low incomes and are non-white may particularly benefit from targeted efforts to improve vitamin D intake.

Topics

vitamin D intake women living with HIV Canada, Prior JC vitamin D women's health cohort study, HIV women dietary vitamin D supplementation bone density, vitamin D deficiency barriers HIV positive women, CARMA cohort vitamin D dietary supplement intake, Canadian Multicentre Osteoporosis Study CaMos vitamin D women, smoking ethnicity income vitamin D supplementation barriers, bone mineral density HIV women vitamin D intake, case-control study vitamin D dairy consumption HIV, vitamin D supplementation promotion HIV care providers
PMID 36597960 36597960 DOI 10.1111/hiv.13454 10.1111/hiv.13454 Elizabeth King et al. 2023, Elizabeth King 2023

Cite this article

King, E. M., Swann, S. A., Prior, J. C., Berger, C., Mayer, U., Pick, N., Campbell, A. R., Côté, H. C. F., Murray, M. C. M., & CIHR team on Cellular Aging and HIV Comorbidities in Women and Children (CARMA) (2023). Vitamin D intakes among women living with and without HIV in Canada. HIV medicine, 24(5), 628-639. https://doi.org/10.1111/hiv.13454

Related articles